Jesse's Journey hits its highest funding year to date and, for the first time, grants $1 million dollars to clinical trials in Canada.
Jesse's Journey funds novel research focused on improving
the delivery of gene therapies (supporting a high unmet need of the Duchenne population with point mutations), and funds the first grant toward patient care and sexual health.